Posters and Presentations
The Michael J. Fox Foundation continually strives to communicate our scientific progress – at meetings, as well as through peer-reviewed scientific publications.
Science Translational Medicine
Inhibition of the kinase activity of leucine-rich repeat kinase 2 (LRRK2) is under investigation as a possible treatment for Parkinson's disease. However, there is no clinical validation as yet, and the safety implications of targeting LRRK2 kinase activity are not well understood. We evaluated the potential safety risks by comparing human and mouse LRRK2 mRNA tissue expression, by analyzing a Lrrk2 knockout mouse model, and by testing sele...READ MORE